NEW YORK (GenomeWeb News) - The Center for Molecular Medicine said today that it will offer three cancer tests developed by AviaraDx in an effort to help physicians make more informed decisions in managing oncology patients.
 
Under the agreement, CMM said it will advise physicians on the value and clinical utility of the AviaraDx tests, and will coordinate sample preparation and shipping. AviaraDx will analyze the tumor samples in its CLIA-certified, CAP-accredited laboratory.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.